000 01281 a2200349 4500
005 20250512020911.0
264 0 _c19891102
008 198911s 0 0 eng d
022 _a0002-8703
024 7 _a10.1016/0002-8703(89)90587-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWatford, W H
245 0 0 _aDiltiazem attenuates the inotropic and peripheral vascular effects of cardiac glycosides.
_h[electronic resource]
260 _bAmerican heart journal
_cOct 1989
300 _a738-47 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAorta
_xphysiology
650 0 4 _aBlood Pressure
650 0 4 _aDiltiazem
_xblood
650 0 4 _aDogs
650 0 4 _aElectrocardiography
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHemodynamics
_xdrug effects
650 0 4 _aMyocardial Contraction
_xdrug effects
650 0 4 _aOuabain
_xantagonists & inhibitors
650 0 4 _aVascular Resistance
_xdrug effects
700 1 _aWalsh, R A
700 1 _aO'Rourke, R A
773 0 _tAmerican heart journal
_gvol. 118
_gno. 4
_gp. 738-47
856 4 0 _uhttps://doi.org/10.1016/0002-8703(89)90587-5
_zAvailable from publisher's website
999 _c2807345
_d2807345